Common questions about Azalia (FAQ)
Q: How is Azalia typically different from combined oral contraceptive pills?
A: According to official product information, Azalia is a progestogen-only pill (POP), meaning it contains only one hormone type. Unlike combined pills, it does not contain the estrogen component. This difference is often relevant for individuals with certain health conditions who are advised to avoid the estrogen component.
Q: Is the potential for blood clots while on Azalia considered different than with the combined pill?
A: Regulatory documents state that the risk of venous thromboembolism (VTE), or blood clots, in users of progestogen-only pills is possibly of similar magnitude as in users of combined pills. Official reports indicate the evidence regarding the risk of VTE specifically for progestogen-only pills is considered less conclusive.
Q: What information exists about Azalia use and the potential for ovarian cysts?
A: Official safety information lists the formation of ovarian cysts as an uncommon side effect that has been reported. These occurrences are noted as part of the overall safety profile.
Q: Can taking antibiotics reduce the effectiveness of Azalia for contraception?
A: Certain medicines, including some anti-infectives (such as Rifampicin and Griseofulvin), are documented in regulatory sources to reduce the plasma concentration of Azalia's active substance. This reduction may lead to critically low blood levels, which is associated with a risk of reduced contraceptive effectiveness.
Q: Does having vomiting or severe diarrhea make Azalia less effective?
A: Official administration guidelines describe a specific protocol if vomiting occurs within two hours, which typically involves taking another tablet immediately. Severe diarrhoea may also affect absorption, and the official protocol advises the use of additional barrier contraception during and after the upset.
Q: How quickly does Azalia start to be effective after the first pill is taken?
A: The official product information indicates that if the first tablet is started on days one to five of the menstrual cycle, contraceptive protection starts without delay. If the medicine is started later than day five, the official protocol advises using additional barrier contraception for the first two days of use.
Q: Does Azalia protect against sexually transmitted infections (STIs)?
A: According to the official safety profile, Azalia, like all hormonal contraceptives, does not protect against sexually transmitted infections (STIs), including HIV infection (AIDS). Additional barrier methods are necessary for protection against sexually transmitted infections.
Q: Can Azalia be used by women who have a history of migraines?
A: Official safety documents list headaches as a very common side effect of the medicine. Official documents indicate that the use of Azalia requires special consideration from a physician in the event of any aggravation or first appearance of certain conditions, including migraines.
Q: How quickly does a person's fertility return after they stop taking Azalia?
A: Studies show that when the medicine was stopped in clinical studies, ovulation (the release of an egg) occurred on average after 17 days.
Q: Is Azalia intended for long-term contraceptive use?
A: The medicine is generally used for sustained periods, and its evidence base includes long-term epidemiological monitoring data to assess sustained use in large populations, which is standard for contraceptives.
Q: What do research studies indicate about the relationship between Azalia and long-term bone mineral density?
A: Studies show that treatment with Azalia leads to decreased levels of the natural hormone estradiol in the blood. Official regulatory documents indicate that it is not yet known whether this decrease has any clinically relevant effect on bone mineral density.
Q: What is the official advice for people who are switching to Azalia from a different contraceptive method?
A: When switching from another progestogen-only pill, the new pack may be started on any day. If switching from a combined pill, the first tablet of Azalia is to be started the day after the last active hormone-containing tablet of the previous pill.
Q: Is it necessary to use a backup method of contraception when starting Azalia?
A: If the medicine is started later than day five of the menstrual cycle, the official protocol advises the use of additional barrier contraception for the first two days of use.
Q: What are the typical side effects that tend to resolve themselves after the first few months of use?
A: Official safety documents note that irregular bleeding, including breakthrough bleeding and spotting, is typically more frequent during the first few months of treatment. This pattern of bleeding is noted as being typical during the initial period of adjustment.
Q: Can Azalia be used to help manage or treat conditions other than contraception?
A: The exclusive primary purpose and core function of the medicine, as defined in regulatory documents, is the prevention of pregnancy (contraception), and it is not intended for the treatment of other medical conditions.
Q: Can Azalia affect the visibility of chloasma (skin darkening)?
A: Official product information advises that women with a tendency to develop chloasma (brown patches on the skin) minimize exposure to the sun or ultraviolet (UV) radiation while taking this medicine.
Q: Is it true that Azalia thins the lining of the womb?
A: Yes, a component of the medicine’s effectiveness involves changing the quality of the womb lining, which is also called the endometrium. This action helps prevent the implantation of a fertilised egg, supporting its contraceptive effect.
Q: What do I need to know about using Azalia if I have a history of high blood pressure?
A: Official safety information indicates that if a patient develops sustained high blood pressure (hypertension) or if an existing high blood pressure condition does not adequately respond to treatment, a physician may consider the discontinuation of the medicine.
Q: What is the information available on Azalia and gallbladder disease?
A: The official safety profile indicates that if a patient has or has had certain conditions, including gallbladder disease, a physician will need to monitor the patient closely during use.
Q: Can Azalia cause a change in vaginal discharge?
A: Changes in vaginal discharge and vaginal infection are listed as uncommon side effects of this medicine in the official product information.
Q: What are the circumstances described in official documents that might require stopping Azalia immediately?
A: Official safety guidance states that discontinuation of the medicine should be considered in the event of a thrombosis (VTE) or in case of long-term immobilisation due to surgery or illness. A physician must be consulted immediately if new or worsening conditions, such as a thrombosis, appear.
Q: Can Azalia be started on a day other than the first day of the period?
A: While the typical protocol is to start the first tablet on the first day of the menstrual cycle, it can be started later. However, if it is started after day five of the cycle, the official protocol advises using additional barrier contraception for the first two days of use.
Q: What happens to the body's natural hormone levels while taking Azalia?
A: Treatment with this medicine is known to lead to decreased levels of the natural hormone estradiol in the blood. This reduction corresponds to the level naturally found in the early follicular phase of the menstrual cycle.
Q: Is it known if Azalia affects the results of any common laboratory tests?
A: Official documents note that oral contraceptives may potentially affect the metabolism of other substances in the body. However, no clinically relevant effects on carbohydrate, lipid metabolism, or blood clotting were observed in clinical studies.
Q: What is the information on Azalia use in relation to a history of depression?
A: Mood changes and depression are listed as possible side effects in the official safety profile. Official safety guidance indicates that for patients who have a history of depression, a physician will provide close monitoring while they are using this medicine.
Q: Is there any evidence to suggest Azalia is harmful to the fetus if taken accidentally during early pregnancy?
A: While Azalia is contraindicated in known or suspected pregnancy, official product information states there is no evidence to suggest that the tablets taken will harm the baby if a user becomes pregnant while on the medicine.
Q: What are the common experiences of users who have been on Azalia for several years?
A: The official evidence base includes long-term epidemiological monitoring data used to assess the effects of sustained use of the medicine over several years. This monitoring contributes to understanding the long-term safety profile.
Q: Can Azalia be used while taking medication for an ongoing chronic condition?
A: Caution and special consideration are required for patients with a history of chronic conditions such as diabetes mellitus or epilepsy. Co-administration of certain medicines used for chronic conditions may significantly reduce the effectiveness of Azalia, and checking for potential interactions is advisable.
Q: What is the advice for users who have concerns about the long-term safety of Azalia?
A: Official safety guidance states that patients are monitored via regular check-ups with their doctor during the treatment period to monitor for any changes or concerns related to long-term use.
Q: What should a user do if they get an unusual rash or hives after starting Azalia?
A: Rash and hives are listed as rare side effects. The official safety guidance states that a physician must be consulted immediately if these or other new, serious conditions, such as a severe rash or hives, appear or worsen during use.
